首页 › 基金 › ORBIMED ADVISORS LLC › CGON
ORBIMED ADVISORS LLC 对 CGON 的持仓历史
CG ONCOLOGY INC · 医疗保健
ORBIMED ADVISORS LLC 在 Q2 2026 的 13F 申报中披露持有 CGON(CG ONCOLOGY INC)972,800 股,市值约 US$69.1M,约占其申报组合的 1.39%,在其申报持仓中市值排名第 19 位。 ORBIMED ADVISORS LLC 最近 8 个申报季度中有 8 个季度披露了 CGON 持仓,最早可追溯至 Q3 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
ORBIMED ADVISORS LLC 对 CGON 的持仓演变
ORBIMED ADVISORS LLC 于 Q3 2024 首次披露 CGON 持仓:691,114 股(约 US$26.1M)。 该持仓在 Q3 2025 达到峰值 1,726,850 股,市值约 US$69.6M。 在 8 次申报中,ORBIMED ADVISORS LLC 4 次增持、3 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 972,800 股、市值约 US$69.1M,环比增持 24,533 股。。 持仓曾出现大幅变动:Q4 2024 增持约 107% (随后一个季度股价下跌 15%)、Q2 2025 减持约 94% (随后一个季度股价上涨 55%)、Q3 2025 增持约 1051% (随后一个季度股价上涨 3%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2024 | 691.11K | $26.08M | 新进 |
| Q4 2024 | 1.43M | $41.04M | 增持 |
| Q1 2025 | 2.47M | $60.54M | 增持 |
| Q2 2025 | 150.00K | $3.90M | 减持 |
| Q3 2025 | 1.73M | $69.56M | 增持 |
| Q4 2025 | 1.52M | $62.97M | 减持 |
| Q1 2026 | 948.27K | $64.18M | 减持 |
| Q2 2026 | 972.80K | $69.12M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CGON 与 13F 数据
CGON(CG ONCOLOGY INC)属于医疗保健行业。我们追踪的基金中还有 52 只申报持有 CGON,申报仓位最大的包括:RTW INVESTMENTS, LP (US$605.0M), Decheng Capital LLC (US$452.7M), TCG Crossover Management, LLC (US$260.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CGON 的基金
- RTW INVESTMENTS, LP 8.51M 股 · $604.96M · Q2 2026
- Decheng Capital LLC 6.37M 股 · $452.71M · Q2 2026
- TCG Crossover Management, LLC 3.67M 股 · $260.77M · Q2 2026
- Foresite Capital Management VI LLC 2.37M 股 · $168.36M · Q2 2026
- Seven Fleet Capital Management LP 1.89M 股 · $134.02M · Q2 2026
- DV Trading LLC 1.44M 股 · $102.27M · Q2 2026
- Avidity Partners Management LP 1.40M 股 · $99.40M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 1.13M 股 · $80.39M · Q2 2026
- Foresite Capital Management V, LLC 1.08M 股 · $76.67M · Q2 2026
- Logos Global Management LP 1.00M 股 · $71.05M · Q2 2026
- Jefferies Financial Group Inc. 769.95K 股 · $54.70M · Q2 2026
- EcoR1 Capital, LLC 561.50K 股 · $39.89M · Q2 2026
更多关于 ORBIMED ADVISORS LLC
常见问题
How long has ORBIMED ADVISORS LLC held CGON?
ORBIMED ADVISORS LLC has disclosed CGON holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is ORBIMED ADVISORS LLC's current position in CGON?
As of Q2 2026, ORBIMED ADVISORS LLC holds 972.80K shares of CGON (CG ONCOLOGY INC), valued at $69.12M, representing 1.39% of its reported portfolio and ranking #19.
Has ORBIMED ADVISORS LLC been buying or selling CGON?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC increased its position in CGON. The position peaked in Q3 2025 at 1.73M shares.
Which other funds hold CGON?
Other major institutional holders of CGON include RTW INVESTMENTS, LP, Decheng Capital LLC, TCG Crossover Management, LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.